FDA approves InteRNA Technologies’ Phase I solid tumour treatment study
The Phase I/Ib trial will assess the pharmacodynamics, pharmacokinetics, preliminary efficacy, and safety of INT-1B3.
News
Acasti Pharma reports positive interim data from SAH therapy trial
The trial will compare and assess GTX-104’s relative bioavailability with the oral nimodipine capsules.
Hepagene begins Phase IIa clinical trial of HPG1860 to treat NASH
The Phase IIa clinical trial will assess the tolerability, efficacy, and safety of HPG1860.
ARCA biopharma completes enrolment in Phase IIb Covid-19 therapy trial
The trial will assess two dose levels of the small recombinant protein versus heparin in...
Ultragenyx Pharmaceutical begins dosing in study of GSDIII therapy
The Phase I/II trial will assess the efficacy, safety, and tolerability of UX053 in GSDIII...
QSAM begins patient enrolment for bone cancer therapy trial
The dose escalation study will determine CycloSam’s maximum tolerated dose in bone cancer patients.
Revelation Biosciences begins Phase IIb trial of H3N2 influenza therapy
The viral challenge study will enrol up to 60 healthy individuals aged 18 to 55 years.
Sobi and Selecta Biosciences complete enrolment for gout therapy trial
The DISSOLVE I study will assess the efficacy and safety of SEL-212 to treat chronic refractory gout.
GreenLight and IAVI partner for Phase I trial of Covid-19 vaccine in Africa
The collaboration aims to expand and speed up access to mRNA vaccines for low-income countries across the world.
Longeveron to explore cell-based therapy in trial of older and frail subjects
Lomecel-B has been assessed in Phase I and II clinical studies in the US for ageing frailty.
Axial Therapeutics begins dosing in Phase IIb autism therapy trial
The study will assess the tolerability, efficacy, and safety of AB-2004 in children aged 13 to 17 years with autism.
